Market Research Logo

Global Gastrointestinal OTC Drugs Market 2015-2019

About gastrointestinal OTC drugs

OTC drugs are medications that do not require a prescription. In contrast, prescription drugs can be sold only to consumers having a legal prescription. OTC drugs are carefully chosen by regulatory agencies to ensure their safety and efficacy. Gastrointestinal OTC drugs can be bought off-the-shelf. Gastrointestinal OTC drugs are used for indications such as GERD, vomiting, constipation, diarrhea, and flatulence. Some of the OTC drugs that are available for the treatment of gastrointestinal diseases are laxatives, anti-flatulents, H2-antaginists, anti-diarrheals, PPIs, and anti-emetics. The OTC drugs are not bound by regulatory guidelines, but need to comply with the drug monograph of a country.

TechNavio's analysts forecast the global gastrointestinal OTC drugs market to grow at a CAGR of 1.48% over the period 2014-2019.

Covered in this report

This report covers the present scenario and the growth prospects of the global gastrointestinal OTC drugs market for the period 2015-2019. To calculate the market size, the report considers revenue from the sales of various OTC drugs available in the market for the management of gastrointestinal disorders such as:

  • GERD/Heartburn
  • Constipation
  • Diarrhea
  • Nausea due to motion sickness
  • Flatulence
The report presents the vendor landscape and a corresponding detailed analysis of the top vendors in the market. In addition, it discusses the major drivers that influence the growth of the market. It also discusses the challenges faced by the vendors and the market at large, as well as the key trends that contribute to the growth the market.

TechNavio's report, Global Gastrointestinal OTC Drugs Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and EMEA and APAC; it also covers the global gastrointestinal OTC drugs market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

Key regions
  • Americas
  • APAC
  • EMEA
Key vendors
  • Bayer
  • GlaxoSmithKline
  • Johnson & Johnson
  • Perrigo
  • Pfizer
  • Procter & Gamble
Other prominent vendors
  • Abbott
  • Boehringer Ingelheim
  • C.B. Fleet
  • Nestle
  • Omega
  • Purdue Pharma
  • Reckitt Benckiser
  • Sanofi
  • Teva Pharmaceutical
Market driver
  • Increase in patient population
  • For a full, detailed list, view our report
Market challenge
  • High spending on advertisement
  • For a full, detailed list, view our report
Market trend
  • Strategic alliances
  • For a full, detailed list, view our report
Key questions answered in this report
  • What will the market size be in 2019 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?


Press Release

Technavio Announces the Publication of its Research Report – Global Gastrointestinal OTC Drugs Market 2015-2019

Technavio recognizes the following companies as the key players in the Global Gastrointestinal OTC Drugs Market 2015-2019: AG, GlaxoSmithKline plc, Johnson & Johnson Ltd., Perrigo Co. plc, Pfizer Inc. and Procter & Gamble Co.

Other Prominent Vendors in the market are: Abbott, Boehringer Ingelheim, C.B. Fleet, Daewoong, Eisai, Nestle, Omega, Purdue Pharma, Reckitt Benckiser, Sanofi, Taisho, Takeda Pharmaceutical and Teva Pharmaceutical.

Commenting on the report, an analyst from Technavio’s team said: “Strategic alliances among vendors that lead to market consolidation are expected to have a positive impact on market growth during the forecast period. Collaborations among the leading vendors help them to obtain an edge over smaller companies.”

According to the report, the increased patient population has a positive impact on market growth. The growing incidence of gastrointestinal disorders and a rise in the geriatric population has led to an increase in the overall patient population. Patients undergo self-diagnosis and self-medication leading to increased consumption of OTC drugs.

Further, the report states that increased expenditure on advertisements of the drugs hinders the growth of the market.

Companies Mentioned

AG, GlaxoSmithKline plc, Johnson & Johnson Ltd., Perrigo Co. plc, Pfizer Inc. and Procter & Gamble Co., Abbott, Boehringer Ingelheim, C.B. Fleet, Daewoong, Eisai, Nestle, Omega, Purdue Pharma, Reckitt Benckiser, Sanofi, Taisho, Takeda Pharmaceutical and Teva Pharmaceutical.

  • Executive Summary
  • List of Abbreviations
  • Scope of the Report
    • Market overview
    • Product offerings
  • Market Research Methodology
    • Market research process
    • Research methodology
      • Table Market research methodology
  • Introduction
  • Overview: OTC Drugs
    • Table Comparison between prescription and OTC drugs
    • Table Advantages and disadvantages of OTC drugs
    • Table Ways to establish an OTC drug in different markets
    • Regulatory pathways for OTC approval
      • Table Key regulatory bodies for OTC approval
    • FDA OTC drug approval process
      • Table FDA OTC drug approval process
      • OTC NDA
        • Table Comparison of NDA versus OTC monograph process
      • OTC drug monograph
        • Table Mechanisms to amend an OTC drug monograph
      • Gastrointestinal prescription to OTC switch
        • Table Drugs underwent Rx-to-OTC switch in US
  • Epidemiology of Gastrointestinal Disorders
  • Market Landscape
    • Market overview
    • Market size and forecast
      • Table Global gastrointestinal OTC drugs market 2014-2019 ($ million)
    • Top predictions
      • Table Top predictions in global gastrointestinal OTC drugs market
    • Five forces analysis
  • Market Segmentation by Therapeutic Class of Drug
    • Table Global gastrointestinal OTC drugs market by therapeutic class of drug
    • Gastric acid reducers
      • Gastric acid neutralizers
      • Laxatives
      • Antidiarrheals
      • Antiemetics
      • Others
        • Table Global gastrointestinal OTC drugs market by therapeutic class of drug 2014
  • Market Segmentation by Indication
    • Table Global gastrointestinal OTC drugs market by indication
    • GERD
      • Constipation
      • Diarrhea
      • Nausea caused by motion sickness
      • Flatulence
  • Geographical Segmentation
    • Table Segmentation of global gastrointestinal OTC drugs market by geography 2014
    • Table Segmentation of global gastrointestinal OTC drugs market by geography 2019
    • Gastrointestinal OTC drugs market in Americas
      • Market size and forecast
        • Table Gastrointestinal OTC drugs market in Americas 2014-2019 ($ million)
    • Gastrointestinal OTC drugs market in EMEA
      • Market size and forecast
        • Table Gastrointestinal OTC drugs market in EMEA 2014-2019 ($ million)
    • Gastrointestinal OTC drugs market in APAC
      • Market size and forecast
        • Table Gastrointestinal OTC drugs market in APAC 2014-2019 ($ million)
  • Buying Criteria
  • Market Growth Drivers
  • Drivers and their Impact
  • Market Challenges
  • Impact of Drivers and Challenges
  • Market Trends
  • Trends and their Impact
  • Vendor Landscape
    • Competitive scenario
      • Key news
      • Mergers and acquisitions
    • Market share analysis 2014
      • Bayer
        • Table Key takeaways: Bayer
      • GlaxoSmithKline
        • Table Key takeaways: GlaxoSmithKline
      • Johnson & Johnson
        • Table Key takeaways: Johnson & Johnson
      • Perrigo
        • Table Key takeaways: Perrigo
        • Table Product portfolio matrix of major vendors
      • Pfizer
        • Table Key takeaways: Pfizer
      • P&G
        • Table Key takeaways: P&G
    • Other prominent vendors
  • Key Vendor Analysis
    • Bayer
      • Key facts
      • Business overview
      • Business segmentation by revenue 2014
        • Table Bayer: business segmentation by revenue 2014
      • Business segmentation by revenue 2013 and 2014
        • Table Bayer: business segmentation by revenue 2013 and 2014 (US$ billion)
      • Geographical segmentation by revenue 2014
        • Table Bayer: geographical segmentation by revenue 2014
      • Business strategy
      • Recent developments
      • SWOT analysis
    • GlaxoSmithKline
      • Key facts
      • Business overview
      • Business segmentation by revenue 2014
        • Table GlaxoSmithKline: business segmentation by revenue 2014
      • Business segmentation by revenue 2013 and 2014
        • Table GlaxoSmithKline: Business segmentation by revenue 2013 and 2014 ($ billion)
      • Geographical segmentation by revenue 2014
        • Table GlaxoSmithKline: geographical segmentation by revenue 2014
      • Business strategy
      • Recent developments
      • SWOT analysis
    • Johnson & Johnson
      • Key facts
      • Business overview
      • Business segmentation by revenue 2014
        • Table Johnson & Johnson: business segmentation by revenue 2014
      • Business segmentation by revenue 2013 and 2014
        • Table Johnson & Johnson: business segmentation by revenue 2013 and 2014 ($ billion)
      • Geographical segmentation by revenue 2014
        • Table Johnson & Johnson: geographical segmentation by revenue 2014
      • Business strategy
      • Recent developments
      • SWOT analysis
    • Perrigo
      • Key facts
      • Business overview
      • Business segmentation by revenue 2014
        • Table Perrigo: business segmentation by revenue 2014
      • Business segmentation by revenue 2013 and 2014
        • Table Perrigo: business segmentation by revenue 2013 and 2014 ($ billion)
      • Geographical segmentation by revenue 2014
        • Table Perrigo: geographical segmentation by revenue 2014
      • Business strategy
      • Recent developments
      • SWOT analysis
    • Pfizer
      • Key facts
      • Business overview
      • Business segmentation by revenue 2014
        • Table Pfizer: business segmentation by revenue 2014
      • Business segmentation by revenue 2013 and 2014
        • Table Pfizer: business segmentation by revenue 2013 and 2014 ($ billion)
      • Geographical segmentation by revenue 2014
        • Table Pfizer: geographical segmentation by revenue 2014
      • Business strategy
      • Key developments
      • SWOT analysis
    • P&G
      • Key facts
      • Business overview
      • Business segmentation by revenue 2014
        • Table P&G: business segmentation by revenue 2014
      • Business segmentation by revenue 2013 and 2014
        • Table P&G: business segmentation by revenue 2013 and 2014 ($ billion)
      • Geographical segmentation by revenue 2014
        • Table P&G: geographical segmentation by revenue 2014
      • Business strategy
      • Recent developments
      • SWOT analysis
  • Other Reports in this Series

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report